Federal Supply Schedule 36F79720D0198

Award Date 9/1/20
Last Date to Order 2/28/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, was awarded a single-award Indefinite Delivery Contract (IDC) worth over $7 million by the Defense Logistics Agency (DLA) Troop Support Medical. This IDC allows Chartwell RX to manufacture and distribute a broad range of pharmaceutical products, including oral antibiotics, antivirals, antiemetics, and antifungals, to military treatment facilities worldwide. Chartwell RX has also been awarded multiple delivery...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract issued by the U.S. Department of Veterans Affairs Veterans Integrated Service Network 12 (VHA VISN 12) to Mylan Pharmaceuticals Inc. The contract, valued at up to $364,546,690.00, provides a comprehensive range of drugs and hematology-related products to VA hospitals and clinics over a 5-year period ending December 31, 2027. As a prime contractor, Mylan Pharmaceuticals will deliver critical medications such as...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) National Acquisition Center. The prime contractor is Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract covers a wide range of pharmaceutical products across multiple therapeutic categories, with a contract ceiling value of $5,914,559,260.00 and a period of performance through June 2028. The...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a for-profit manufacturer of pharmaceutical and healthcare products. The contract, valued at $32,885,990.00, is for the provision of pharmaceuticals, drugs, and hematology-related products (FSS-61-IB) to the VA and other federal agencies. The contract has an ultimate completion date of September 1, 2025 and was originally awarded on April 15, 2017. It is...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024. The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under GSA Schedule 65IB for Pharmaceuticals and Drugs, awarded to Xlcare Pharmaceuticals Inc. The $450,000.00 ceiling value contract has a period of performance from March 1, 2021 to February 28, 2026. As a prime contractor, Xlcare is a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract enables Xlcare to supply a variety of...
The Federal Supply Schedule contract 36F79722D0068 was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Chartech Inc., a Service-Disabled Veteran-Owned Small Business, on February 1, 2022. The multiple-award contract has a ceiling value of $11,334,530 and runs through January 31, 2027, allowing Chartech to provide a wide range of medical equipment and supplies across various Special Item Numbers (SINs) on the GSA Schedule 65 II A. Under this contract, Chartech...
The federal contract IDV award, valued at over $61.8 billion, is a Pharmaceutical Prime Vendor (PPV) contract issued by the Department of Veterans Affairs (VA) National Acquisition Center. The contract was competitively awarded to Mckesson Corporation, a prominent healthcare services and IT company, to provide just-in-time distribution of government-contracted pharmaceuticals to VA facilities, other government agencies, and state veterans homes across the United States, Puerto Rico, and...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...

The federal contract IDV award with the Department of Veterans Affairs (VA) provides Chartwell RX LLC, a for-profit pharmaceutical company, a $225,000 Federal Supply Schedule contract to supply pharmaceuticals and hematology-related products to the Veterans Integrated Service Network (VISN) 12 through October 2025. Additionally, Chartwell RX holds a $7 million single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to manufacture and distribute a broad spectrum of medications, including oral antibiotics, antivirals, antiemetics, and antifungals, to military treatment facilities worldwide through March 2030.

Separately, Chartwell RX was awarded a $139.7 million firm fixed price delivery order contract by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to supply doxycycline hyclate tablets and amoxicillin trihydrate capsules for the Strategic National Stockpile over a two-year period through June 2025. This contract was set aside for small businesses, leveraging Chartwell RX's experience as a federal contractor and its proven track record of fulfilling delivery orders for various medications.

Generated 6/3/25, 10:04 AM